The FDA’s Convoluted Stance on Abortion Pills Doesn’t Protect Patients — It Endangers Them
By Sarah Christopherson and Olivia Snavely, National Women’s Health Network Under federal law, the U.S. Food and Drug Administration (FDA) can impose Risk Evaluation and Mitigation Strategies (REMS) on drugs that it believes could do more harm than good if not carefully controlled. While all medications pose some health risks, some are more dangerous than others, […]